Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
10,700
-27,800
-72% -$272K ﹤0.01% 1068
2026
Q1
$243K Buy
38,500
+23,200
+152% +$209K 0.01% 928
2025
Q4
$164K Buy
+15,300
New +$168K 0.01% 845
2024
Q3
Sell
-49,871
Closed -$141K 648
2024
Q2
$141K Sell
49,871
-11,568
-19% -$82.5K 0.01% 543
2024
Q1
$968K Buy
61,439
+37,511
+157% +$634K 0.07% 279
2023
Q4
$470K Buy
23,928
+11,381
+91% +$198K 0.03% 352
2023
Q3
$256K Buy
12,547
+4,337
+53% +$109K 0.02% 596
2023
Q2
$240K Buy
+8,210
New +$225K 0.02% 607
2022
Q1
Sell
-9,065
Closed -$695K 988
2021
Q4
$695K Buy
9,065
+4,250
+88% +$375K 0.04% 577
2021
Q3
$463K Buy
+4,815
New +$526K 0.03% 897

Other funds holding CRNC

Winton Group's CRNC Position: Q2 2026 in Review

Winton Group reduced its Cerence (CRNC) stake by 72% in Q2 2026, selling an estimated $272K and leaving 10,700 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Winton Group first reported a position in CRNC in Q3 2021 and has held it in 10 quarters since. The position peaked at $968K in Q1 2024. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Winton Group held 10,700 shares of Cerence worth $121K as of Q2 2026.
  • Winton Group sold 27,800 Cerence shares in Q2 2026, an estimated $272K.
  • Cerence made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1068 holding.
  • Winton Group first reported a position in Cerence in Q3 2021 and has held it in 10 quarters since.
  • Winton Group's Cerence position peaked at $968K in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.